124 related articles for article (PubMed ID: 37982100)
1.
Urso L; Rocca GC; Conti GM; Colella A; Nieri A; Cittanti C; Ippolito C; Bartolomei M
Nucl Med Mol Imaging; 2023 Dec; 57(6):298-300. PubMed ID: 37982100
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of
Gao J; Xu Q; Fu Y; He K; Zhang C; Zhang Q; Shi J; Zhao X; Wang F; Guo H
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):561-569. PubMed ID: 32623502
[TBL] [Abstract][Full Text] [Related]
3. Special issue "The advance of solid tumor research in China": 68Ga-PSMA-11 PET/CT for evaluating primary and metastatic lesions in different histological subtypes of renal cell carcinoma.
Li Y; Zheng R; Zhang Y; Huang C; Tian L; Liu R; Liu Y; Zhang Z; Han H; Zhou F; He L; Dong P
Int J Cancer; 2023 Jan; 152(1):42-50. PubMed ID: 35751420
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of [
Wang G; Li L; Wang J; Zang J; Chen J; Xiao Y; Fan X; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1499-1509. PubMed ID: 36600099
[TBL] [Abstract][Full Text] [Related]
5. High Prognostic Value of
Gasparro D; Scarlattei M; Silini EM; Migliari S; Baldari G; Cervati V; Graziani T; Campanini N; Maestroni U; Ruffini L
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835825
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings.
Gühne F; Seifert P; Theis B; Steinert M; Freesmeyer M; Drescher R
Diagnostics (Basel); 2021 Jun; 11(7):. PubMed ID: 34201583
[TBL] [Abstract][Full Text] [Related]
8. 18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma.
Urso L; Rocca GC; Uccelli L; Ippolito C; Bartolomei M
Clin Nucl Med; 2023 Apr; 48(4):e178-e180. PubMed ID: 36728284
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparisons of
Lin BH; Chen SH; Chen SM; Qiu QR; Gao RC; Wei Y; Zheng QS; Miao WB; Xu N
Int Urol Nephrol; 2023 Nov; 55(11):2753-2764. PubMed ID: 37477778
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.
Rizzo A; Racca M; Dall'Armellina S; Rescigno P; Banna GL; Albano D; Dondi F; Bertagna F; Annunziata S; Treglia G
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672305
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of
Hoffmann MA; Miederer M; Wieler HJ; Ruf C; Jakobs FM; Schreckenberger M
Oncotarget; 2017 Dec; 8(67):111073-111083. PubMed ID: 29340038
[TBL] [Abstract][Full Text] [Related]
12. [
Meng L; Zhang S; Gao J; Xu Q; Fu Y; Zhou YH; Wang F; Guo H
Eur Radiol; 2022 Sep; 32(9):6545-6553. PubMed ID: 35357538
[TBL] [Abstract][Full Text] [Related]
13. The use of
Raveenthiran S; Esler R; Yaxley J; Kyle S
Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2280-2288. PubMed ID: 31332498
[TBL] [Abstract][Full Text] [Related]
14.
Gao J; Meng L; Xu Q; Zhao X; Deng Y; Fu Y; Guo S; He K; Shi J; Wang F; Zhang S; Guo H
Mol Imaging Biol; 2022 Oct; 24(5):759-768. PubMed ID: 35451707
[TBL] [Abstract][Full Text] [Related]
15. PET/CT using
Liu D; Cheng G; Ma X; Wang S; Zhao X; Zhang W; Yang W; Wang J
J Neuroimaging; 2021 Jul; 31(4):733-742. PubMed ID: 34021667
[TBL] [Abstract][Full Text] [Related]
16. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with
Kalshetty A; Menon B; Rakshit S; Bhattacharjee A; Basu S
J Nucl Med Technol; 2021 Sep; 49(3):235-240. PubMed ID: 34244223
[TBL] [Abstract][Full Text] [Related]
17. Intra-Individual Comparison of Physiologic [
Novruzov E; Schmitt D; Mattes-György K; Beu M; Mori Y; Dabir M; Radtke JP; Niegisch G; Albers P; Schimmöller L; Antoch G; Antke C; Giesel FL; Mamlins E
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345124
[TBL] [Abstract][Full Text] [Related]
18.
Klingenberg S; Jochumsen MR; Ulhøi BP; Fredsøe J; Sørensen KD; Borre M; Bouchelouche K
J Nucl Med; 2021 Feb; 62(2):214-220. PubMed ID: 32444374
[TBL] [Abstract][Full Text] [Related]
19.
Kesler M; Levine C; Hershkovitz D; Mishani E; Menachem Y; Lerman H; Zohar Y; Shibolet O; Even-Sapir E
J Nucl Med; 2019 Feb; 60(2):185-191. PubMed ID: 30002112
[No Abstract] [Full Text] [Related]
20. Diverse PSMA expression in primary prostate cancer: reason for negative [
Cytawa W; Kircher S; Kübler H; Werner RA; Weber S; Hartrampf P; Bandurski T; Lass P; Połom W; Matuszewski M; Wester HJ; Lapa C; Rosenwald A; Seitz AK; Buck AK
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3938-3949. PubMed ID: 35556160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
